141 related articles for article (PubMed ID: 6776756)
1. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly.
Hanew K; Sasaki A; Mouri T; Yoshinaga K
Acta Endocrinol (Copenh); 1980 Nov; 95(3):298-307. PubMed ID: 6776756
[No Abstract] [Full Text] [Related]
2. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC
Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686
[TBL] [Abstract][Full Text] [Related]
3. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
Hanew K; Aida M; Sasaki A; Mouri T; Yoshinaga K
Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
[TBL] [Abstract][Full Text] [Related]
4. [Response of growth hormone to sandostatin and bromocriptine and prognostic value of prolactin levels in serum and thyroliberin test in patients with active acromegaly].
Gasińska T; Nowak S
Endokrynol Pol; 1993; 44(4):455-65. PubMed ID: 8055814
[TBL] [Abstract][Full Text] [Related]
5. Long-term bromocriptine therapy and predictive tests in acromegaly.
Karashima T; Kato K; Nawata H; Ikuyama S; Ibayashi H; Okamura K; Shiroozu A; Nakashima T; Fujishima M
Endocrinol Jpn; 1986 Apr; 33(2):163-7. PubMed ID: 3093202
[TBL] [Abstract][Full Text] [Related]
6. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
[No Abstract] [Full Text] [Related]
8. Lack of effect of thyroid hormones on the growth hormone response to thyrotropin-releasing hormone in acromegaly.
Carlson HE; Sowers JR; Rand RW
Metabolism; 1977 Jul; 26(7):801-5. PubMed ID: 405552
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
Werner S; Hall K; Sjöberg HE
Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
[TBL] [Abstract][Full Text] [Related]
10. Effect of bromocriptine on serum hormones in acromegaly.
Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.
Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
Acta Endocrinol (Copenh); 1987 Sep; 116(1):53-8. PubMed ID: 2889308
[TBL] [Abstract][Full Text] [Related]
12. The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly.
Hanew K; Sugawara A; Shimizu Y; Sato S; Sasaki A; Tazawa S; Ishii K; Saitoh T; Saso S; Yoshinaga K
Endocrinol Jpn; 1989 Jun; 36(3):429-38. PubMed ID: 2510991
[TBL] [Abstract][Full Text] [Related]
13. Factors determining the effectiveness of CB-154 in the treatment of acromegaly.
Hanew K; Sasaki A; Sato S; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1983 Jan; 139(1):91-5. PubMed ID: 6404005
[No Abstract] [Full Text] [Related]
14. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.
Moses AC; Molitch ME; Sawin CT; Jackson IM; Biller BJ; Furlanetto R; Reichlin S
J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
Felt V; Nedvídková J
Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
[No Abstract] [Full Text] [Related]
16. The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly.
Roelfsema F; Goslings BM; Frölich M; Moolenaar AJ; Seters AP; Van Slooten H
Clin Endocrinol (Oxf); 1979; 11(2):235-44. PubMed ID: 114344
[TBL] [Abstract][Full Text] [Related]
17. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
18. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
[TBL] [Abstract][Full Text] [Related]
19. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
Samaan NA; Leavens ME; Jesse RH
J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
[No Abstract] [Full Text] [Related]
20. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
